Institute for Medical Technology Assessment, Erasmus Medical Centre, Rotterdam
Department of Health Policy and Management, Erasmus Medical Centre, Rotterdam and Trimbos Institute, Utrecht
Institute for Medical Technology Assessment, Erasmus Medical Centre, Rotterdam
Department of Health Policy and Management, Erasmus Medical Centre, Rotterdam, The Netherlands
Correspondence: Dr Leona Hakkaart-van Roijen, Institute for Medical Technology Assessment, PO Box 1738, 3000 DR Rotterdam, The Netherlands. Tel: +31 10 4088567; fax: +31 10 4089081; e-mail: l.hakkaart-vanroijen{at}erasmusmc.nl
Declaration of interest None. Funding detailed in Acknowledgements.
Background The cost-utility of brief therapy compared with cognitivebehavioural therapy (CBT) and care as usualin the treatment of depression and anxiety has not yet been determined.
Aims To assess the cost-utility of brief therapy compared with CBT and care as usual.
Method A pragmatic randomised controlled trial involving 702 patients was conducted at 7 Dutch mental healthcare centres (MHCs). Patients were interviewed at baseline and then every 3 months over a period of 1.5 years, during which time data were collected on directcosts, indirect costs and quality of life.
Results The mean direct costs of treatment at the MHCs were significantly lower for brief therapy than for CBTand care as usual.However, after factoring in other healthcare costs and indirect costs, no significant differences between the treatment groups could be detected.We found no significant differences in quality-adjusted life-years between the groups.
Conclusions Cost-utility did not differ significantly between the three treatment groups.
Related articles in BJP:
This article has been cited by other articles:
![]() |
M. Hoogendoorn, C. R. van Wetering, A. M. Schols, and M. P. M. H. Rutten-van Molken Is INTERdisciplinary COMmunity-based COPD management (INTERCOM) cost-effective? Eur. Respir. J., January 1, 2010; 35(1): 79 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Barton, J. Hodgekins, M. Mugford, P. B. Jones, T. Croudace, and D. Fowler Measuring the benefits of treatment for psychosis: validity and responsiveness of the EQ-5D The British Journal of Psychiatry, August 1, 2009; 195(2): 170 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Seivewright, J. Green, P. Salkovskis, B. Barrett, U. Nur, and P. Tyrer Cognitive-behavioural therapy for health anxiety in a genitourinary medicine clinic: randomised controlled trial The British Journal of Psychiatry, October 1, 2008; 193(4): 332 - 337. [Abstract] [Full Text] [PDF] |
||||